Discovering new anti-malaria drugs to treat one of the world's biggest health problems

Malaria remains a major global health problem with nearly half of the world's population at risk of contracting malaria. In 2020, the World Health Organisation estimated there were 240 million cases of malaria and more than 620,000 deaths. It is also a disease of inequity with nearly all malaria deaths occurring in African children.
 
To mark  World Malaria Day, QIMR Berghofer researcher, Associate Professor Bridget Barber discusses the need for new anti-malaria drugs.

Her research group is at the forefront of malaria research where they inoculate volunteer groups with malaria to test new drugs and evaluate their safety and efficacy. And as host Bridie Barry discovers, recent published findings are promising.